Tyra Biosciences Holds Annual Meeting, Elects Directors
Ticker: TYRA · Form: 8-K · Filed: May 31, 2024 · CIK: 1863127
| Field | Detail |
|---|---|
| Company | Tyra Biosciences, Inc. (TYRA) |
| Form Type | 8-K |
| Filed Date | May 31, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, annual-meeting, stockholder-vote
Related Tickers: TYRA
TL;DR
Tyra Bio shareholders voted on directors and auditors; expect governance updates.
AI Summary
On May 29, 2024, Tyra Biosciences, Inc. filed an 8-K report detailing several key events. The company announced the results of its annual meeting of stockholders, including the election of directors and the ratification of its independent registered public accounting firm. Additionally, the filing indicates potential amendments to the company's charter or bylaws and modifications to security holder rights.
Why It Matters
This filing provides shareholders with crucial information regarding corporate governance and the company's strategic direction as determined by stockholder votes.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance matters and stockholder votes, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Tyra Biosciences, Inc. (company) — Registrant
- May 29, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-40800 (filing_id) — Commission File Number
- 83-1476348 (tax_id) — IRS Employer Identification No.
- 2656 State Street Carlsbad, California 92008 (address) — Principal Executive Offices
- (619) 728-4760 (phone_number) — Registrant's Telephone Number
FAQ
What were the primary items voted on at Tyra Biosciences' annual meeting of stockholders?
The filing indicates that the annual meeting of stockholders involved the election of directors and the ratification of the company's independent registered public accounting firm.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 29, 2024.
What is Tyra Biosciences, Inc.'s state of incorporation?
Tyra Biosciences, Inc. is incorporated in Delaware.
What is the Commission File Number for Tyra Biosciences, Inc.?
The Commission File Number for Tyra Biosciences, Inc. is 001-40800.
Where are Tyra Biosciences, Inc.'s principal executive offices located?
Tyra Biosciences, Inc.'s principal executive offices are located at 2656 State Street, Carlsbad, California, 92008.
Filing Stats: 797 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2024-05-31 16:02:00
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share TYRA Nasdaq Global Select
Filing Documents
- d807421d8k.htm (8-K) — 39KB
- d807421dex31.htm (EX-3.1) — 5KB
- 0001193125-24-151705.txt ( ) — 170KB
- tyra-20240529.xsd (EX-101.SCH) — 3KB
- tyra-20240529_lab.xml (EX-101.LAB) — 18KB
- tyra-20240529_pre.xml (EX-101.PRE) — 11KB
- d807421d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Certificate of Amendment of Amended and Restated Certificate of Incorporation, dated May 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TYRA BIOSCIENCES, INC. Date: May 31, 2024 By: /s/ Ali Fawaz Name: Ali Fawaz Title: General Counsel and Secretary